← Back to Search

Imaging Device

VIO Imaging for Skin Abnormalities (VISTA Trial)

N/A

Waitlist Available

Led By Michael Wang, MD, FAAD

Research Sponsored by Enspectra Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months post enrollment completion

Awards & highlights

VISTA Trial Summary

This trial tests a device that can get images of skin tissue features and show if they match up to biopsy results.

Eligible Conditions

Skin Abnormalities
Skin Cancer
Skin Diseases
Skin Conditions
Skin Lesions

VISTA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months post enrollment completion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months post enrollment completion

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post enrollment completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Safety and Effectiveness

Secondary outcome measures

1) 90% inter-reader agreement during image analysis phase of the study on the images captured using the investigational device

2) Evaluation of secondary histopathology characteristics using a questionnaire to identify skin features on the images captures on investigational device VIO

VISTA Trial Design

1Treatment groups

Experimental Treatment

Group I: VIO ImagingExperimental Treatment1 Intervention

Subjects with skin conditions that are candidates for biopsy

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

VIO Imaging

2022

N/A

~70

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Enspectra HealthLead Sponsor

1 Previous Clinical Trials

122 Total Patients Enrolled

1 Trials studying Skin Abnormalities

122 Patients Enrolled for Skin Abnormalities

National Cancer Institute (NCI)NIH

13,704 Previous Clinical Trials

40,931,377 Total Patients Enrolled

2 Trials studying Skin Abnormalities

1,122 Patients Enrolled for Skin Abnormalities

National Institutes of Health (NIH)NIH

2,715 Previous Clinical Trials

7,510,333 Total Patients Enrolled

1 Trials studying Skin Abnormalities

122 Patients Enrolled for Skin Abnormalities

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the criteria for participation in this trial?

"This medical trial is hoping to recruit 65 people with skin conditions, ranging in age from 18-99 years old. To be eligible for the study, individuals must meet specific requirements including: being of legal consenting age; granting written informed permission; preparing for a biopsy procedure; and possessing adequate cognitive capacity to comprehend the ICF and comply with necessary protocol elements."

Answered by AI

Does this trial require participants to be under 55 years of age?

"This trial is open to people aged 18-99, with 15 separate studies available for minors and 42 for senior citizens."

Answered by AI

Are there any open spots available for this clinical trial?

"Affirmative. According to the clinicaltrials.gov page, this trial is in progress and actively seeking participants since its first posting on October 20th 2022. 65 individuals are needed across one study site, with the most recent update posted on November 11th 2022."

Answered by AI

How many participants are eligible to join this research project?

"Affirmative. The clinical trial is actively searching for participants, and the relevant information on clinicaltrials.gov confirms this. Initially posted in October of 2022, the study was recently updated in November 2022; 65 patients are needed from a single medical facility to complete it."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

VIO Imaging for Skin Tissue Assessment (VISTA)

2022. "VIO Imaging for Skin Tissue Assessment (VISTA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05619471.